Babao, Darwin, Jr. C.
HRN: 27-91-10 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/15/2025
CEFTAZIDIME 1GM (VIAL)
10/15/2025
10/22/2025
IV DRIP
92mg
Q12h
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes